Table 1: Review of the patients with intraoperatively detected HCC during bariatric surgery.
| Pt. no. | Age & sex | BMI | HBS Ag | Anti-HCV | Fatty liver | Triglycerides | Liver chemistry | DM | Bariatric procedure | Size (CM) | Segment | HPE | AFP level (ng/ml) | Outcome |
| 1 | 30F | 29 | Negative | Negative | Yes | High | Normal | Yes | DJB-SG | 6 × 5 × 4 | 3 | HCC, well encapsulated, clear margins |
1 | Follow up- 2 yr -No chemotherapy. HbA1C reduced from 10.6% to 6.9% |
| 2 | 30F | 43.7 | Positive | Negative | Yes | Normal | Normal | No | LSG | 3 × 2 | 3 | HCC, margins involved | 74 | Follow up- 7 yr -(disease free). Systemic chemotherapy given, as patient refused angiography or other invasive treatments. Weight reduced from 121.9 kg to 90 kgs |
DJB-SG: Duodeno Jejunal Bypass with Sleeve Gastrectomy; LSG: Laparoscopic Sleeve Gastrectomy; DM: Type 2 Diabetes Mellitus, HPE: Histopathology Report, AFP: Alpha-Fetoprotein, HCC: Hepatocellular Carcinoma.